Unicycive Therapeutics, Inc.
UNCY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $26,142 | $9,701 | $455 | $16,579 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4,806 | $3,698 | $2,189 | $1,832 |
| Total Curr. Assets | $30,948 | $13,399 | $2,644 | $18,411 |
| Property Plant & Equip (Net) | $720 | $792 | $174 | $333 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $720 | $792 | $174 | $333 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $31,668 | $14,191 | $2,818 | $18,744 |
| Liabilities | – | – | – | – |
| Payables | $966 | $821 | $846 | $742 |
| Short-Term Debt | $656 | $345 | $201 | $180 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $22,498 | $16,368 | $2,237 | $1,183 |
| Total Curr. Liab. | $24,120 | $17,534 | $3,284 | $2,105 |
| LT Debt | $117 | $466 | $0 | $155 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $117 | $466 | $0 | $155 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $681 | $793 | $155 | $306 |
| Total Liabilities | $24,237 | $18,000 | $3,284 | $2,260 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $114 | $35 | $15 | $15 |
| Retained Earnings | -$101,270 | -$64,541 | -$33,997 | -$15,939 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $108,587 | $60,697 | $33,516 | $32,408 |
| Total Equity | $7,431 | -$3,809 | -$466 | $16,484 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $31,668 | $14,191 | $2,818 | $18,744 |
| Net Debt | -$25,369 | -$8,890 | -$254 | -$16,244 |